EGFR targeted therapy of neurological disorders and pain

• 收藏
• 分享

专利权人:

Sykehuset Sorlandet HF

发明人:

Kersten, Christian,Cameron, Marte Gronlie,Mjaland, Svein

申请号：

AU2013362134

公开号：

AU2013362134B2

申请日:

2013.12.20

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain. The invention relates in more detail to compositions comprising inhibitors of EGFR

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/